$91.00
▼ -0.7% Today
as of Jul 22, 16:47 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 9
▼ 0
Colgate-Palmolive (CL) Faces A Margin Growth Debate, Is The Upside Already Priced In?
Colgate-Palmolive (CL) Stock Looks Rich Relative To Its Earnings Valuation
2 Reasons to Like CL (and 1 Not So Much)
Overview
52-week range
$75
$99
66% of range
Avg surprise (last 2)
+4.6%
Avg reaction (last 1)
+1.3%
100% positive
Latest IV / EM
29%
EM ±1.7% · $92 · Jul 24
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.80 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.91 | — | — | — | — | financials |
| Fri Aug 1, 2025 | Jun/2025 | $0.92 | $0.89 | +3.4% | — | — | earnings |
| Fri Apr 25, 2025 | Mar/2025 | $0.91 | $0.86 | +5.8% | — | +1.3% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.90 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.89 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.83 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.86 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.60 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Jul 31, 2026 | Jun/2026 | BMO | $0.95 | $0.92 | +3.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $2.10B | — | $2.08B | $2.04B | $1.92B | — | $1.96B | $1.99B |
| Gross profit | $3.23B | — | $3.05B | $3.07B | $2.99B | — | $3.07B | $3.07B |
| Operating income | $964M | — | $1.06B | $1.08B | $1.08B | — | $1.06B | $1.09B |
| Net income | $646M | — | $735M | $743M | $690M | — | $737M | $731M |
| EPS (diluted) | $0.80 | — | $0.91 | $0.91 | $0.85 | — | $0.90 | $0.89 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $1.33B | $1.29B | $1.28B | $1.22B | $1.11B | $1.10B | $1.23B | $1.11B |
| Inventory | $2.09B | $2.03B | $2.11B | $2.12B | $2.12B | $1.99B | $2.04B | $1.92B |
| Total current assets | $6.08B | $5.71B | $6.04B | $6.00B | $5.81B | $5.32B | $5.81B | $5.65B |
| Total assets | $16.61B | $16.33B | $17.51B | $17.47B | $16.65B | $16.05B | $16.77B | $16.48B |
| Long-term debt | $7.94B | $6.87B | $7.31B | $7.14B | $6.57B | $7.29B | $7.91B | $8.15B |
| Total liabilities | $16.12B | $15.96B | $16.27B | $16.42B | $15.91B | $15.50B | $15.94B | $16.00B |
| Total equity | $145M | $54M | $856M | $702M | $363M | $212M | $435M | $123M |